Clinical Trials Browser

Phase 2 × Olanzapine × Tumor-Agnostic × Clear all

NCT02400866 2015-03-27

A Randomized Study of Olanzapine for the Prevention of CINV in Patients Receiving Moderately Emetogenic Chemotherapy

Phase 2 Unknown

Neoplasms